Shares of MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report) shot up 0.2% on Wednesday . The company traded as high as $0.40 and last traded at $0.39. 420,793 shares were traded during mid-day trading, an increase of 214% from the average session volume of 134,123 shares. The stock had previously closed at $0.39.
MyMD Pharmaceuticals Stock Up 0.2 %
The stock has a fifty day simple moving average of $0.73 and a two-hundred day simple moving average of $1.17.
About MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
Featured Articles
- Five stocks we like better than MyMD Pharmaceuticals
- 3 Small Caps With Big Return Potential
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- How to find penny stocks to invest and trade
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How to Find Undervalued Stocks
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
